151 related articles for article (PubMed ID: 29485078)
1. Hippocampal Sparing During Craniospinal Irradiation: What Did We Learn About the Incidence of Perihippocampus Metastases?
Padovani L; Chapon F; André N; Boucekine M; Geoffray A; Bourdeau F; Masliah-Planchon J; Claude L; Huchet A; Laprie A; Supiot S; Coche-Dequéant B; Kerr C; Alapetite C; Leseur J; Nguyen T; Chapet S; Bernier V; Bondiau PY; Noel G; Habrand JL; Bolle S; Doz F; Dufour C; Muracciole X; Carrie C
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):980-986. PubMed ID: 29485078
[TBL] [Abstract][Full Text] [Related]
2. Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing.
Baliga S; Adams JA; Bajaj BVM; Van Benthuysen L; Daartz J; Gallotto SL; Lewy JR; DeNunzio N; Weyman EA; Lawell MP; Palmer JD; Yeap BY; Ebb DH; Huang MS; Perry AF; MacDonald SM; Jones RM; Tarbell NJ; Yock TI
Cancer; 2023 Mar; 129(5):764-770. PubMed ID: 36504293
[TBL] [Abstract][Full Text] [Related]
3. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy?
Burcu A; Nazan Ç; Özgür Ö; Serra K; Mehmet K; Serap A; Bengü D; Canan V; Haldun Ö; Savaş K; Tuncer T; Taner A; Yeşim E; Ömer K; Yavuz A
Childs Nerv Syst; 2018 Sep; 34(9):1657-1662. PubMed ID: 29868932
[TBL] [Abstract][Full Text] [Related]
4. Is Hippocampal Avoidance During Whole-Brain Radiotherapy Risky for Patients With Small-Cell Lung Cancer? Hippocampal Metastasis Rate and Associated Risk Factors.
Korkmaz Kirakli E; Oztekin O
Technol Cancer Res Treat; 2017 Dec; 16(6):1202-1208. PubMed ID: 29332467
[TBL] [Abstract][Full Text] [Related]
5. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
[TBL] [Abstract][Full Text] [Related]
6. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
[TBL] [Abstract][Full Text] [Related]
7. Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933.
Gondi V; Tome WA; Marsh J; Struck A; Ghia A; Turian JV; Bentzen SM; Kuo JS; Khuntia D; Mehta MP
Radiother Oncol; 2010 Jun; 95(3):327-31. PubMed ID: 20392503
[TBL] [Abstract][Full Text] [Related]
8. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival.
Oehlke O; Wucherpfennig D; Fels F; Frings L; Egger K; Weyerbrock A; Prokic V; Nieder C; Grosu AL
Strahlenther Onkol; 2015 Jun; 191(6):461-9. PubMed ID: 25592907
[TBL] [Abstract][Full Text] [Related]
9. Verification of Low Risk for Perihippocampal Recurrence in Patients with Brain Metastases Who Received Whole-Brain Radiotherapy with Hippocampal Avoidance.
Kim Y; Kim SH; Lee JH; Kang DG
Cancer Res Treat; 2019 Apr; 51(2):568-575. PubMed ID: 30011983
[TBL] [Abstract][Full Text] [Related]
10. Optimization of Craniospinal Irradiation for Pediatric Medulloblastoma Using VMAT and IMRT.
Al-Wassia RK; Ghassal NM; Naga A; Awad NA; Bahadur YA; Constantinescu C
J Pediatr Hematol Oncol; 2015 Oct; 37(7):e405-11. PubMed ID: 26334433
[TBL] [Abstract][Full Text] [Related]
11. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts.
Prokic V; Wiedenmann N; Fels F; Schmucker M; Nieder C; Grosu AL
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):264-70. PubMed ID: 22516808
[TBL] [Abstract][Full Text] [Related]
12. Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning.
Acharya S; Guo Y; Patni T; Li Y; Wang C; Gargone M; Ashford JM; Wilson L; Faught A; Reddick WE; Patay Z; Gajjar A; Conklin HM; Merchant TE
J Clin Oncol; 2022 Jan; 40(1):83-95. PubMed ID: 34714708
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Hippocampal Avoidance Whole Brain Radiotherapy on the Preservation of Long-Term Neurocognitive Function in Non-Small Cell Lung Cancer Patients With Brain Metastasis.
Wang B; Fu S; Huang Y; Liu L; Liang Y; An W; Fan Y; Zhao Y
Technol Cancer Res Treat; 2021; 20():15330338211034269. PubMed ID: 34396867
[TBL] [Abstract][Full Text] [Related]
14. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401
[TBL] [Abstract][Full Text] [Related]
15. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
Sethi RV; Giantsoudi D; Raiford M; Malhi I; Niemierko A; Rapalino O; Caruso P; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):655-63. PubMed ID: 24521681
[TBL] [Abstract][Full Text] [Related]
16. Initial experiences with hippocampus-sparing whole-brain radiotherapy for lung cancer patients.
Nielsen M; Kristiansen C; Schytte T; Hansen O
Acta Oncol; 2019 Oct; 58(10):1540-1542. PubMed ID: 31303085
[No Abstract] [Full Text] [Related]
17. Incidence of hippocampal metastases in non-small-cell lung cancer.
Ly S; Lehman M; Liu H; Hukins C; Murphy M; Dauth M; Devine MS; Mai GT
J Med Imaging Radiat Oncol; 2020 Aug; 64(4):586-590. PubMed ID: 32627418
[TBL] [Abstract][Full Text] [Related]
18. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
Suzuki S; Kato T; Murakami M
J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of hippocampal avoidance whole brain radiation in patients with hippocampal involvement: Data from a prospective study.
Lee G; Besse L; Lamba N; Hancox C; Usta I; Hacker F; Catalano P; Brown PD; Tanguturi S; Pashtan I; Phillips J; Haas-Kogan D; Alexander B; Cagney D; Aizer A
Med Dosim; 2021 Spring; 46(1):21-28. PubMed ID: 32778521
[TBL] [Abstract][Full Text] [Related]
20. Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation.
Kundapur V; Ellchuk T; Ahmed S; Gondi V
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):781-6. PubMed ID: 25752392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
